RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Clinical trials for RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to boost Cancer-Killing power of CAR-T
Disease control Recruiting nowThis early-phase study is testing the safety and effectiveness of a new drug called ST-067 when given alongside a personalized immune cell therapy (CAR-T) for patients with aggressive large B-cell lymphoma that has come back or not responded to other treatments. The goal is to se…
Matched conditions: RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Cancer trial aims to slash radiation time and side effects
Disease control Recruiting nowThis study is testing whether a shorter, lower-dose course of radiation therapy works as well as the standard, longer course for treating slow-growing non-Hodgkin lymphoma. The main goal is to see if the shorter treatment causes fewer immediate side effects while still controllin…
Matched conditions: RECURRENT INDOLENT B-CELL NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC